October 17, 2024
Pliant Therapeutics
Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024
October 16, 2024
Candid Therapeutics
Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to its Board of Directors
October 15, 2024
Maze Therapeutics
Maze Therapeutics to Present New Data Supporting Advancement of MZE829 and MZE782 Clinical Development at American Society of Nephrology's Kidney Week and American Society of Human Genetics Annual Meeting.
October 11, 2024
insitro
insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases
October 08, 2024
MOMA Therapeutics
Bayer and MOMA Therapeutics enter collaboration and license agreement in Oncology